University of Tennessee Advanced Studies in Pharmacy: Volume 2, (13) Goals

GOAL
To provide an in-depth analysis of the newly released Adult Treatment Panel III Cholesterol Guidelines, what they dictate, as well as the impact they have on cardiologists, internists, primary care physicians, and other health care providers.

TARGET AUDIENCE
This activity is designed for cardiologists, internists, primary care physicians, nurses, pharmacists, and other health care providers.

LEARNING OBJECTIVES
After reading this issue, the participant should be able to:

Identify which compliance issues prevent patients from achieving the full benefit of combination therapy in the treatment of hypercholesterolemia
Understand the value of additional markers, beyond the standard lipid profile, in determining a global risk assessment and overall approach to patient management
Discuss the clinical evidence supporting the benefits of combination therapy in treating hypercholesterolemia

ACCREDITATION STATEMENT
This activity has been planned and produced in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this continuing medical education activity for a maximum of 1 hour in Category 1 credit toward the American Medical Association Physicians' Recognition Award. Each physician should claim only those hours of credit that are actually spent on the educational activity. Credits are available until the expiration date of September 30, 2004.

This continuing medical education activity was produced under the supervision of Roger S. Blumenthal, MD, Associate Professor of Medicine, Johns Hopkins University School of Medicine, and Director of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, and Peter O. Kwiterovich, Jr, MD, Professor of Medicine and Pediatrics, Johns Hopkins University School of Medicine, and Director of the Johns Hopkins University Lipid Clinic.

This program is approved for 1 hour of credit (0.1 CEUs) and is co-sponsored by The University of Tennessee College of Pharmacy who is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. ACPE Program #064-999-02-222-H01.

This continuing pharmacy education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean of Continuing Education, University of Tennessee College of Pharmacy.

CONTINUING NURSING EDUCATION ACCREDITATION
This educational activity has been approved for 1 contact hour by the Institute for Johns Hopkins Nursing, which is accredited as a provider of continuing education in nursing by the American Nurses' Credentialing Center's Commission on Accreditation. Credit will be awarded until September 30, 2004. This continuing nursing education activity was produced under the supervision of Kathleen H. Sabatier, MS, RN, Director, The Institute for Johns Hopkins Nursing.

This program is supported by an unrestricted educational grant from Sankyo Pharma.

Publisher's Note and Disclaimer: The opinions expressed in this issue are those of the authors, presenters, and/or panelists and are not attributable to the publisher, editor, advisory board of Advanced Studies in Medicine, or The Johns Hopkins University School of Medicine or its Office of Continuing Medical Education. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this issue are not necessarily the same as indicated in the package insert for the product and may reflect the clinical experience of the authors, presenters, and/or panelists or may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.